Type 2 Diabetes Remission in 56% on very low CALORIE diet over 12 month Very impressive!! diabetesjournals.org/care/article/4…

Observational modelling data suggests that in PPL with chronic liver disease and type 2 #diabetes who adhered to therapy over time, GLP1R agonists may result in lower risk of major adverse liver outcomes #MAFLD #MASLD #cancer #cirrhosis Gut Journal gut.bmj.com/content/early/…

Real world data from the USA on semagluide and decreased risk of stroke link.springer.com/article/10.100… #T2D

Once-a-month maridebart cafraglutide is a GIPR antagonist conjugated to GLP-1 analogues that promotes 14.5% weight loss with improved metabolic parameters. nature.com/articles/s4225…

In the placebo-controlled LIXIPARK phase 2 trial involving persons with Parkinson’s disease, the subcutaneous GLP-1 receptor agonist lixisenatide was associated with reduced motor disability over a period of 12 months. Read the full trial results: nej.md/3J68HF8

How do we manage #Diabetes #Dementia? Let's find out from the international society of #endocrinology. youtu.be/fEOybQFqI70?si… Dementia UK Nature Neuroscience NeurologyNewsLA Dr Kallol Dey Dementia Australia Dementia Friends Ayush Sharma Ministry of Health World Health Organization (WHO) World Health Organization South-East Asia Age_and_Ageing

Retrospective real world data in both PPL with #obesity and studies #T2D demonstrate that semaglutide is associated with a 50%-56% lower risk for both the incidence and recurrence of alcohol use disorder for a 12-month follow-up period Nature Communications nature.com/articles/s4146…

#AddisonsDiseaseAwarenessDay: Do listen to experts from America, Europe, Africa, Asia discuss #Adrenal #advocacy. Topics include #Endocrinologist as Sherlock Holmes, Metabolic syndrome as Cushingoid precursor, Essential drugs in adrenal medicine youtube.com/live/2rJYZFyYR… adrenal kortex 3

You know I love myself some metformin Metformin may be as safe as insulin during #pregnancy, 11-year data shows endocrine.org/news-and-advoc… #diabetes #endocrine Endocrine Society

Fenofibrate 145mg in early diabetic retinopathy or maculopathy for 4 years reduced progression of #retinopathy by 27% and reduced development of diabetic macular edema. Let’s rediscover an old friend! An oldie but a goodie! #ADASciSessions evidence.nejm.org/doi/full/10.10…

As GLP-1 science expands beyond glucose control #T2D and #weightloss new indications are being explored in the clinic, highlighting potential roles for GLP-1 in neuroprotection, substance use disorders, metabolic liver disease and more Science Magazine science.org/doi/10.1126/sc…

ይህን ምስል ፕሮፋይል ፎቶ በማድረግ ወገኖቻችንን ቢያንስ ለሶስት ቀናት እናስብ የሚመለከተው አካል ብሄራዊ የሀዘን ቀን አውጆ ባንዲራ ዝቅ ብሎ እንዲውለበለብ ካላደረገ እኛ በራሳችን ለምን አናደርገውም? እድሜ ለሶሻል ሚድያ! የሟቾች ቁጥር

Meet Yonas Alemu: The Ethiopian Entrepreneur Who Exported Teff Pasta to Italy addisinsight.net/2024/08/meet-y… via AddisInsight

This is a nice review of the role of incretin receptor agonists in the treatment of obesity. …ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…

A pooled analysis of 4 trials extends the benefits of semaglutide #heartfailure beyond symptoms and functional capacity to reduction of emergency hospitalization visits and a composite endpoint including CV death The Lancet thelancet.com/journals/lance…

Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients | VuMedi vumedi.com/video/evolving… via @vumedi

Our December 2024 issue is online now! link.springer.com/journal/125/vo…

Semaglutide improves sperm morphology in men with functional hypogonadism, obesity, and type 2 diabetes. …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

youtu.be/xKrw9LIkAeU?si…